Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 5
1999 4
2000 7
2001 9
2002 6
2003 18
2004 16
2005 22
2006 32
2007 22
2008 33
2009 40
2010 46
2011 65
2012 66
2013 68
2014 58
2015 74
2016 18
2018 1
2019 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

538 results
Results by year
Filters applied: . Clear all
Page 1
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.
Loi S, Dushyanthen S, Beavis PA, Salgado R, Denkert C, Savas P, Combs S, Rimm DL, Giltnane JM, Estrada MV, Sánchez V, Sanders ME, Cook RS, Pilkinton MA, Mallal SA, Wang K, Miller VA, Stephens PJ, Yelensky R, Doimi FD, Gómez H, Ryzhov SV, Darcy PK, Arteaga CL, Balko JM. Loi S, et al. Clin Cancer Res. 2016 Mar 15;22(6):1499-509. doi: 10.1158/1078-0432.CCR-15-1125. Epub 2015 Oct 29. Clin Cancer Res. 2016. PMID: 26515496 Free PMC article.
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.
Balko JM, Giltnane JM, Wang K, Schwarz LJ, Young CD, Cook RS, Owens P, Sanders ME, Kuba MG, Sánchez V, Kurupi R, Moore PD, Pinto JA, Doimi FD, Gómez H, Horiuchi D, Goga A, Lehmann BD, Bauer JA, Pietenpol JA, Ross JS, Palmer GA, Yelensky R, Cronin M, Miller VA, Stephens PJ, Arteaga CL. Balko JM, et al. Cancer Discov. 2014 Feb;4(2):232-45. doi: 10.1158/2159-8290.CD-13-0286. Epub 2013 Dec 19. Cancer Discov. 2014. PMID: 24356096 Free PMC article.
Microbial Regulation of p53 Tumor Suppressor.
Zaika AI, Wei J, Noto JM, Peek RM. Zaika AI, et al. PLoS Pathog. 2015 Sep 17;11(9):e1005099. doi: 10.1371/journal.ppat.1005099. eCollection 2015 Sep. PLoS Pathog. 2015. PMID: 26379246 Free PMC article. Review.
Toward a science of tumor forecasting for clinical oncology.
Yankeelov TE, Quaranta V, Evans KJ, Rericha EC. Yankeelov TE, et al. Cancer Res. 2015 Mar 15;75(6):918-23. doi: 10.1158/0008-5472.CAN-14-2233. Epub 2015 Jan 15. Cancer Res. 2015. PMID: 25592148 Free PMC article. Review.
Nanoparticle detection of respiratory infection.
Halfpenny KC, Wright DW. Halfpenny KC, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 May-Jun;2(3):277-90. doi: 10.1002/wnan.83. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010. PMID: 20201109 Free PMC article. Review.
Accessibility control of V(D)J recombination.
Cobb RM, Oestreich KJ, Osipovich OA, Oltz EM. Cobb RM, et al. Adv Immunol. 2006;91:45-109. doi: 10.1016/S0065-2776(06)91002-5. Adv Immunol. 2006. PMID: 16938538 Review.
Does lapatinib work against HER2-negative breast cancers?
Mayer IA, Arteaga CL. Mayer IA, et al. Clin Cancer Res. 2010 Mar 1;16(5):1355-7. doi: 10.1158/1078-0432.CCR-09-3223. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179241 Free PMC article. Review.
538 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page